Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

 

Search in our Online Store

Generics
Filter     Order     Display # 
Date Item Title
16 Apr 2008 Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)
14 Apr 2008 Oramed Pharmaceuticals Commences Phase 2A Clinical Trials in Israel
08 Apr 2008 Ranbaxy becomes first foreign generic company to develop a generic product independently outside Japan and receive authorisation from MHLW
04 Apr 2008 Neutropenia: Biosimilar Product from India Moves One Step Closer to European Market
03 Apr 2008 Ranbaxy launches worlds first bio-generic recombinant injectible for the treatment of osteoporosis in India
03 Apr 2008 Taro Receives Tentative FDA Approval for Lamotrigine Tablets ANDA
28 Mar 2008 NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society
25 Mar 2008 Taro Receives FDA Approval for Ondansetron Hydrochloride Injection USP, 2 mg/mL ANDA
13 Mar 2008 Watson Files FDA Application for Generic LYBREL(R)
12 Mar 2008 Sandoz enhances patient access with launch of Omnitrope(TM) Pen 5
12 Mar 2008 Barr Receives Approval for Generic Taxol(R) Injection USP, 6mg/mL
12 Mar 2008 TPG Biotech to Fund Development of JCR Pharmaceuticals Drug Candidates
11 Mar 2008 Akorn-Strides, LLC Announces FDA Approval for
29 Feb 2008 Actavis receives FDA approval for Irinotecan Hydrochloride Injection; extends US portfolio with first injectable product
28 Feb 2008 Teva Announces Approval Of Generic Camptosar(R)
27 Feb 2008 APP Pharmaceuticals Receives Final Approval for Irinotecan Hydrochloride Injection
21 Feb 2008 Teva's Developed G-CSF is the First Biosimilar to Receive a Positive Opinion from European Union Regulators
21 Feb 2008 Ratiopharm receives positive opinion from EMEA for filgrastim
19 Feb 2008 Barr Receives Final Approval for Generic Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg
11 Feb 2008 Biocon acquires 70% stake in German Pharmaceutical company, AxiCorp: Biosimilars will be main focus
08 Feb 2008 APP Pharmaceuticals Receives FDA Approval for Bleomycin Sulfate for Injection, USP
08 Feb 2008 APP Pharmaceuticals Receives FDA Approval for Caffeine Citrate Oral Solution, USP
07 Feb 2008 Ranbaxy receives tentative approval to manufacture and market Esomeprazole Magnesium DR capsules in USA
06 Feb 2008 Teva Announces Approval of Generic Fosamax(R) Tablets
06 Feb 2008 Ranbaxy Gains Approval to Manufacture and Market Cefuroxime Axetil for Oral Suspension
01 Feb 2008 Teva Announces Tentative Approval Of Generic Flomax(R) Capsules
01 Feb 2008 Aurobindo Pharma gets tentative approval for Sumatriptan Succinate
01 Feb 2008 Mylan Announces Final FDA Approval for Granisetron Hydrochloride Tablets
30 Jan 2008 IMPAX Receives FDA Non-Approvable Letter for Vadova(R); Company Considering Options
29 Jan 2008 Nycomed and Wyeth announce launch of an own generic version of PROTONIX(R)
24 Jan 2008 Cangene's recombinant human growth hormone approved by the U.S. Food and Drug Administration
23 Jan 2008 Teva Announces Tentative Approval of Generic Prevacid(R) Delayed-Release Capsules
22 Jan 2008 FDA approves additional indication for Astellas' Mycamine (R)
22 Jan 2008 Taro Receives FDA Approval of New Drug Application for Flo-Pred(TM) (Prednisolone Acetate Oral Suspension)
17 Jan 2008 Teva Announces Approval Of Pravastatin Sodium Tablets, 80 Mg
17 Jan 2008 APP Pharmaceuticals Receives FDA Approval for Polymyxin B Sulfate for Injection, USP
14 Jan 2008 Teva Announces Tentative Approval Of Generic Aricept(R) Tablets
14 Jan 2008 Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Children's Zyrtec(R) Chewable Tablets for Allergy Relief and Children's Zyrtec(R) Chewable Tablets for Hives Relief
14 Jan 2008 Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Metaglip(R)
03 Jan 2008 Teva Announces Approval Of Generic Kytril(R) Injection And Tablets
02 Jan 2008 Watson Receives FDA Approval for Generic DuoNeb(R)
02 Jan 2008 Barr Receives Approval for Generic KYTRIL(R) Tablets, 1mg (Base)
31 Dec 2007 Ranbaxy receives final approval to manufacture and market cetirizine hydrochloride tablets (OTC), 5mg and 10mg
31 Dec 2007 Mylan Announces Final FDA Approval for Balsalazide Disodium Capsules
30 Dec 2007 Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lexapro(R)
28 Dec 2007 Mylan Announces Final FDA Approval for Cetirizine Hydrochloride Tablets
28 Dec 2007 Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Zyrtec Allergy Tablets(R) and Zyrtec Hives Relief Tablets(R)
24 Dec 2007 Teva Announces Launch Of Generic Protonix(R) Tablets, 20 Mg And 40 Mg,
19 Dec 2007 STADA receives approval for Erythropoietin-zeta
12 Dec 2007 AstraZeneca Files Patent Infringement Actions in Response to Crestor(TM) ANDAs
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 Next > End >>
Results 51 - 100 of 409

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Emerging Diabetes Drugs

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics